Biomedical innovation in the era of health care spending constraints.
about
How does venture capital operate in medical innovation?Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies.A Concurrent Analysis of Three Institutions that Transform Health Technology-Based Ventures: Economic Policy, Capital Investment, and Market ApprovalHow venture capitalists decide which new medical technologies come to exist
P2860
Biomedical innovation in the era of health care spending constraints.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Biomedical innovation in the era of health care spending constraints.
@en
Biomedical innovation in the era of health care spending constraints.
@nl
type
label
Biomedical innovation in the era of health care spending constraints.
@en
Biomedical innovation in the era of health care spending constraints.
@nl
prefLabel
Biomedical innovation in the era of health care spending constraints.
@en
Biomedical innovation in the era of health care spending constraints.
@nl
P1433
P1476
Biomedical innovation in the era of health care spending constraints.
@en
P2093
James C Robinson
P304
P356
10.1377/HLTHAFF.2014.0975
P407
P577
2015-02-01T00:00:00Z